Filing Details
- Accession Number:
- 0001140361-13-006041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-12 16:06:28
- Reporting Period:
- 2013-02-08
- Filing Date:
- 2013-02-12
- Accepted Time:
- 2013-02-12 16:06:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189844 | J Robert Easton | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-08 | 12,500 | $9.18 | 89,842 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-08 | 12,500 | $36.05 | 77,342 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-02-10 | 390 | $36.11 | 77,732 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock option (right to buy) | Disposition | 2013-02-08 | 12,500 | $0.00 | 12,500 | $9.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-04-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | By Trust |
Footnotes
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $35.99 to $36.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- The shares were issued pursuant to the Issuer's director stock election policy whereby non-employee directors may elect to receive fully-vested shares of common stock in lieu of between 50-100% of their annual cash retainers and committee chair fees. The price per share was based on the fair market value of the Issuer's common stock on the date of issuance, which, because such date was a Sunday, was the NASDAQ closing price on the last trading date immediately preceding the date of issuance.
- Shares are held by the Second Easton Family Charitable Trust of which the Reporting Person is the trustee.
- The stock option grant is 100% vested and immediately exercisable.
Billionaire Hedge Funds
